Endemic fungal infections in patients receiving tumour necrosis factor-alpha inhibitor therapy.
about
TNF biology, pathogenic mechanisms and emerging therapeutic strategiesRecent advances in our understanding of the environmental, epidemiological, immunological, and clinical dimensions of coccidioidomycosisInvasive fungal infections in pediatric patients treated with tumor necrosis alpha (TNF-α) inhibitorsInterferon alpha treatment of patients with impaired interferon gamma signaling.Conidia but not yeast cells of the fungal pathogen Histoplasma capsulatum trigger a type I interferon innate immune response in murine macrophages.Clinical use of anti-TNF therapy and increased risk of infectionsMyD88-dependent signaling drives host survival and early cytokine production during Histoplasma capsulatum infection.CCR5 deficiency mitigates the deleterious effects of tumor necrosis factor α antagonism in murine histoplasmosisGeographic distribution of endemic fungal infections among older persons, United States.Endemic mycoses in immunocompromised hosts.Paracoccidioidomycosis induced by immunosuppressive drugs in a patient with rheumatoid arthritis and bone sarcoma: case report and review of the literature.Diagnosis and management of infectious complications of childhood rheumatic diseases.Infectious and malignant complications of TNF inhibitor therapy in IBD.Beyond tumor necrosis factor inhibition: the expanding pipeline of biologic therapies for inflammatory diseases and their associated infectious sequelae.Thermally Dimorphic Human Fungal Pathogens--Polyphyletic Pathogens with a Convergent Pathogenicity Trait.Juvenile idiopathic arthritis: management and therapeutic options.Screening for tuberculosis and hepatitis B prior to the initiation of anti-tumor necrosis therapy.Clinical Manifestations and Treatment of Blastomycosis.Monoarthritis in a 28-Year-Old Man With Juvenile Idiopathic Arthritis.Central Nervous System Infections Associated with Immunosuppressive Therapy for Rheumatic Disease.Case Report: Histoplasmosis: First Autochthonous Case from Israel.Cave diving for a diagnosis: Disseminated histoplasmosis in the immunocompromised.
P2860
Q26776492-76C942FF-9218-4382-9742-BC52DA47A1A6Q28675835-F44D707D-7D83-4B3B-9EB1-EA2584E99605Q29302324-1C1A1220-24B2-4AB2-8FEB-74EAD0487873Q34059742-A6BC4311-41C8-41E9-A5DB-A2EB12D7DD53Q34119470-DA221F7B-4968-42E1-A671-8CC658DB3C5CQ34338096-39DF81B7-E318-4731-8A5A-EE6CFD4A5BB5Q35187518-54B67E2F-528E-4C32-B74F-EC7A8D776FF0Q35766007-8C1FE990-DAA8-4598-818A-7B134CE7F34AQ35877516-9BA58215-5C55-425F-A1CE-8D9DBBC56BDDQ37080529-6299A11F-583A-40B8-ACC9-055E06B47387Q37848719-4D2949FA-5902-4B54-BDC7-B5EF7CF82108Q38084889-6C0E26BB-CBD7-4C55-96C7-A851667AA784Q38138343-DA41AE67-C9C6-4D54-AAC5-E26E02B33416Q38192553-12201F96-5840-48B5-BB92-9896A8BCFBCBQ38266680-30C98D2C-0306-4E73-AD6A-057E72C61A11Q39243858-D73AB629-8465-48EF-AB81-E474153F96F1Q40000660-039C1366-7AB5-4839-8A93-7D79576A94EBQ40098273-AEB8EA88-DF88-4B05-ACD2-70838D5BBB14Q41363297-4F0E2608-3E7C-4503-AFFD-713E17FF3DCEQ46339578-CFA18C1F-1E9A-4D92-B0F5-BEDF009ADB7EQ49816430-C77C0C05-5F7E-48AD-9C3D-85C276BF58D4Q55331076-537F1277-DD37-4565-9D76-5F86483E0EB0
P2860
Endemic fungal infections in patients receiving tumour necrosis factor-alpha inhibitor therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Endemic fungal infections in p ...... actor-alpha inhibitor therapy.
@en
Endemic fungal infections in p ...... actor-alpha inhibitor therapy.
@nl
type
label
Endemic fungal infections in p ...... actor-alpha inhibitor therapy.
@en
Endemic fungal infections in p ...... actor-alpha inhibitor therapy.
@nl
prefLabel
Endemic fungal infections in p ...... actor-alpha inhibitor therapy.
@en
Endemic fungal infections in p ...... actor-alpha inhibitor therapy.
@nl
P2860
P1433
P1476
Endemic fungal infections in p ...... actor-alpha inhibitor therapy.
@en
P2093
Carol A Kauffman
Jeannina A Smith
P2860
P304
P356
10.2165/00003495-200969110-00002
P577
2009-07-01T00:00:00Z
P6179
1002313608